Under construction – not a live service
Sign in
Not yet taking people in SpainNo phase

Studies a silver mesh to prevent wound infection and hernia after belly surgery

Observes a silver mesh device used to prevent wound infection and hernia in adults.

Plain-language title generated from the registry record
Registry title: Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)

Key facts

Where
Badalona, Calella, Mataró, and Santa Coloma de Gramenet, SpainSee the 5 sites

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who need an urgent first midline abdominal surgery (laparotomy) with a contaminated or dirty-infected surgical field. It tests a silver mesh to prevent wound infection and hernia.

Age
18 years or older
Sex
All sexes can join
Disease stage
Urgent first midline laparotomy, classed as Class III (contaminated) or Class IV (dirty-infected) by the CDC
Earlier treatment
No previous laparotomy and no previous hernia repair

Main reasons for not taking part

  • Pregnancy or breast feeding
  • Allergy to silver or to parts of the device
  • Previous laparotomy or previous hernia repair
  • Active cancer treatment (chemotherapy or radiotherapy)
  • Underlying autoimmune disease

Read by machine on 12 November 2026.

Where in Spain

  • Hospital Municipal BadalonaBadalona, SpainContact: Jorge Marroquin, Dr.No longer taking part
  • Hospital Universitari Germans Tries i PujolBadalona, SpainContact: Joan Francesc Julián, Dr.No longer taking part
  • Hospital Comarcal Sant Jaume de CalellaCalella, SpainContact: Paqui Vasco, Dr.No longer taking part
  • Hospital de MataróMataró, SpainContact: Berhanu Chimdi, Dr.No longer taking part
  • Hospital Fundació Esperit SantSanta Coloma de Gramenet, SpainContact: Daniel Troyano Escribano, Dr.No longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Aesculap AG
Trial code
NCT06547138
Record updated
6 November 2026
Original description
The aim of the study is to describe the effectiveness of Optilene® Silver Mesh Elastic on prevention of surgical site infection (SSI) at 6 months follow-up in patients undergoing urgent laparotomy by collecting clinical data on the SSI rates, IH rates and overall clinical performance of Optilene® Silver Mesh Elastic used for the prevention of incisional hernia as prophylactic mesh in patients that require urgent median laparotomy in clinical routine.Read full original descriptionShow less

Prospective Descriptive Multicentre Pilot Study On The Effectiveness and Safety Of Optilene® Silver Mesh Elastic In Prevention Of Surgical Site Infection (SSI) And Incisional Hernia (IH)

The aim of the study is to describe the effectiveness of Optilene® Silver Mesh Elastic on prevention of surgical site infection (SSI) at 6 months follow-up in patients undergoing urgent laparotomy by collecting clinical data on the SSI rates, IH rates and overall clinical performance of Optilene® Silver Mesh Elastic used for the prevention of incisional hernia as prophylactic mesh in patients that require urgent median laparotomy in clinical routine.

Inclusion: Adult patients (18 years or older); Surgical procedure requiring urgent, primary median laparotomy, which are classified as "Class III/Contaminated" or "Class IV/Dirty-Infected" regarding the CDC classification; These include but are not limited to:; Vascular surgery; Colon and rectum; Hepatobiliary; Gastrointestinal; Gynecology; Urology; Abdominal Aortic Aneurysm (AAA) repair; Right hemicolectomy; Left hemicolectomy; Sigmoidectomy; Anterior resection; Abdominoperineal amputation; Exploratory laparotomy; Cholecystectomy; Cholecystectomy and choledocotomy; Written informed consent.

Exclusion: Previous allergic reactions to components of the device; Patient with previous laparotomy; Patients with previous hernia repair; Simultaneous participation in another investigational clinical trial (drug or medical studies); Patients with active oncologic treatment (chemo and radiotherapy); Gynecology surgery; Urology surgery; Vascular surgery; Contaminated and infected areas; Hypersensitivity to silver; Underlying autoimmune disease; Patients < 18 years old or patients who are still in the growth phase; Pregnancy; Breast feeding; Direct contact with the viscera; Transverse laparotomy; Recent cardiovascular complication.

ClinicalTrials.gov NCT06547138